相关实验视频
Updated: Jan 6, 2026

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
24.1K
针对原发性阿尔多斯特龙症的单边上腺切除术后持续性宁抑制:对不良结果的影响?
Isabel Stüfchen1, Tracy Ann Williams1, Júnia R O L Schweizer1
1Department of Medicine IV, Endocrinology, Diabetology and Metabolism, LMU University Hospital, LMU Munich, Munich, Germany.
The Journal of clinical endocrinology and metabolism
|November 1, 2025
概括
在一次性阿尔多斯特症手术后持续抑制蛋白是常见的,并且与较差的生化结果有关,尽管大多数患者仍能达到缓解. 上腺切除术后被抑制的蛋白水平对临床结果没有影响.
科学领域:
- 内分泌学 在内分泌学.
- 心血管医学 心血管医学
- 手术瘤学手术瘤学
背景情况:
- 原发性阿尔多斯特龙症 (PA) 患者在药物治疗中使用抑制的氨酸,其心脏代谢结果较差.
- 没有研究研究了PA单边上腺切除术后的持续性宁抑制.
- 这项研究研究了侧面化PA中上腺切除术后宁抑制的患病率和影响.
研究的目的:
- 为了研究侧向PA的上腺切除术后六个月持续宁抑制的患病率.
- 评估持续氨酸抑制对上腺切除术后生化和临床结果的影响.
主要方法:
- 追溯分析77名为侧向PA进行上腺切除术的患者.
- 根据术后直接宁度 (DRC) 将患者分为三级.
- 评估组织病理学,生化缓解 (PASO标准) 和临床结果长达三年.
主要成果:
- 较低的DRC (<8mU/l) 与较高的非经典组织病理学流行率 (30.8%) 和更频繁的缺席/部分生化缓解 (34.6%) 相相关.
- 尽管如此,65.4%的患者实现了完全的生化缓解.
- 在DRC三角动物之间没有观察到临床结果的显著差异,包括末端器官损伤和并发症.
结论:
- 持续性氨酸抑制是PA的上腺切除术后六个月的一个常见发现.
- 列宁抑制与更糟糕的生化结果有关,但不会影响临床结果.
- 超过60%的患有宁抑制 (<8mU/l) 的患者实现了完全的生化缓解.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
1.2K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
869
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
869
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
1.3K
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.3K
Adrenal Gland Disorders
2.8K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.8K
Hormonal Regulation
35.6K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.6K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.2K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.2K

